Table 4.
Complete comparison of clinical and imaging data in mortality and survivors’ group
| Baseline characteristics (n = 86) | Survivors (n = 75) | Death (n = 11) | P value |
|---|---|---|---|
| Age (years), mean ± SD | 58.89 ± 15.33 | 58.82 ± 19.92 | 0.948 |
| Sex (male) | 47 (90.4%) | 5 (9.6%) | 0.20 |
| Comorbidities | |||
| Diabetes | 27 (93.1%) | 2 (6.9%) | 0.208 |
| COPD | 3 (100%) | 0 (0%) | 0.66 |
| Smoking | 4 (100%) | 0 (0%) | 0.556 |
| Hyperlipidemia | 9 (100%) | 0 (0%) | 0.273 |
| CVA | 3 (100%) | 0 (0%) | 0.66 |
| Cancer | 4 (80%) | 1 (20%) | 0.504 |
| Coronary artery disease | 20 (95.2%) | 1 (4.8%) | 0.190 |
| Heart failure | 1 (100%) | 0 (0%) | 0.872 |
| CKD | 6 (75%) | 2 (25%) | 0.271 |
| Hypertension | 32 (88.9%) | 4 (11.1%) | 0.478 |
| Echocardiographic data (n = 86) | Survivors (n = 75) | Death (n = 11) | P value |
|---|---|---|---|
| LVEF (%), mean ± SD | 47.79 ± 8.88 | 50.68 ± 4.04 | 0.517 |
| Normal/Mild LV systolic dysfunction | 60 (84.5%) | 11 (15.5%) | 0.522 |
| Moderate LV systolic dysfunction | 10 (100%) | 0 (0%) | |
| Severe LV systolic dysfunction | 5 (100%) | 0 (0%) | |
| LV diastolic dysfunction | 46 (82.1%) | 10 (17.9%) | 0.055 |
| sPAP (mmHg), mean ± SD | 27.32 ± 5.88 | 32.78 ± 6.18 | 0.007 |
| Pericardial effusion | |||
| None | 71 (87.7%) | 10 (12.3%) | 0.274 |
| Minimal | 3 (100%) | 0 (0%) | |
| Mild | 0 (0%) | 1 (100%) | |
| Moderate | 1 (100%) | 0 (0%) | |
| TAPSE | 21.4 ± 4.07 | 19.8 ± 3.61 | 0.258 |
| Chest CT findings (n = 50) | Survivors (n = 43) | Death (n = 7) | P value |
|---|---|---|---|
| Total CT score | 7.31 ± 3.20 | 8.57 ± 4.80 | 0.361 |
| Distribution | |||
| Left sided | 2 (100%) | 0 (0%) | 0.536 |
| Right sided | 2 (100%) | 0 (0%) | |
| Bilateral | 39 (84.8%) | 7 (15.2%) | |
| Pattern | |||
| GGO | 23 (85.2%) | 4 (14.8%) | 0.593 |
| Consolidation | 20 (87%) | 3 (13%) | |
| Result | |||
| Intermediate | 5 (83.3%) | 1 (16.7%) | 0.616 |
| Highly suggestive | 38 (86.4%) | 6 (13.6%) | |
CKD chronic kidney disease, COPD chronic obstructive pulmonary disease, CVA cerebrovascular accident, GGO ground glass opacification, LVEF left ventricular ejection fraction, sPAP systolic pulmonary artery pressure, TAPSE tricuspid annular systolic plane excursion